Cargando…
Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
BACKGROUND: Allergen immunotherapy (AIT) is effective in patient with local allergic rhinitis (LAR). However, AIT may not always achieve the optimal treatment effect. OBJECTIVE: To present short study with clinical cases of LAR combined therapy with sublingual immunotherapy (SLIT) and omalizumab in...
Autores principales: | Bozek, Andrzej, Kozłowska, Renata, Misiołek, Maciej, Ścierski, Wojciech, Gawlik, Radosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746402/ https://www.ncbi.nlm.nih.gov/pubmed/35816437 http://dx.doi.org/10.1080/21645515.2022.2097818 |
Ejemplares similares
-
Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients
por: Nittner-Marszalska, Marita, et al.
Publicado: (2022) -
Update about Oralair® as a treatment for grass pollen allergic rhinitis
por: Klimek, L., et al.
Publicado: (2022) -
Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis
por: Bożek, Andrzej, et al.
Publicado: (2023) -
Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022) -
The aspects of local allergic rhinitis in Polish children and adolescents
por: Bożek, Andrzej, et al.
Publicado: (2023)